View in EDS

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Saved in:
Bibliographic Details
Title: CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.
Authors: Rankin AW; Division of Hematology, Oncology & Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH.; Department of Pediatrics, The Ohio State University, Columbus, OH., Myers RM; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Lamble AJ; Division of Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, WA., Hsieh EM; Division of Hematology/Oncology/Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA., Sankaran H; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD., Chen L; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Annesley C; Division of Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, WA., DiNofia AM; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Grupp SA; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Pulsipher MA; Division of Hematology and Oncology, Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Dolan JG; Division of Hematology and Oncology, Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Bhojwani D; Division of Hematology/Oncology/Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA., Gardner RA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Shah NN; National Cancer Institute/Center for Cancer Research, Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD., Rheingold SR; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
Source: Blood advances [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3467-3479.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41701972
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rankin+AW%22">Rankin AW</searchLink>; Division of Hematology, Oncology & Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH.; Department of Pediatrics, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Myers+RM%22">Myers RM</searchLink>; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Lamble+AJ%22">Lamble AJ</searchLink>; Division of Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Hsieh+EM%22">Hsieh EM</searchLink>; Division of Hematology/Oncology/Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Sankaran+H%22">Sankaran H</searchLink>; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Annesley+C%22">Annesley C</searchLink>; Division of Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22DiNofia+AM%22">DiNofia AM</searchLink>; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Grupp+SA%22">Grupp SA</searchLink>; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Pulsipher+MA%22">Pulsipher MA</searchLink>; Division of Hematology and Oncology, Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Dolan+JG%22">Dolan JG</searchLink>; Division of Hematology and Oncology, Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Bhojwani+D%22">Bhojwani D</searchLink>; Division of Hematology/Oncology/Transplantation and Cellular Therapy, Children's Hospital Los Angeles Cancer and Blood Disease Institute, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Gardner+RA%22">Gardner RA</searchLink>; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.<br /><searchLink fieldCode="AU" term="%22Shah+NN%22">Shah NN</searchLink>; National Cancer Institute/Center for Cancer Research, Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Rheingold+SR%22">Rheingold SR</searchLink>; Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3467-3479.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41701972
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025018604
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3467
    Titles:
      – TitleFull: CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rankin AW
      – PersonEntity:
          Name:
            NameFull: Myers RM
      – PersonEntity:
          Name:
            NameFull: Lamble AJ
      – PersonEntity:
          Name:
            NameFull: Hsieh EM
      – PersonEntity:
          Name:
            NameFull: Sankaran H
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Annesley C
      – PersonEntity:
          Name:
            NameFull: DiNofia AM
      – PersonEntity:
          Name:
            NameFull: Grupp SA
      – PersonEntity:
          Name:
            NameFull: Pulsipher MA
      – PersonEntity:
          Name:
            NameFull: Dolan JG
      – PersonEntity:
          Name:
            NameFull: Bhojwani D
      – PersonEntity:
          Name:
            NameFull: Gardner RA
      – PersonEntity:
          Name:
            NameFull: Shah NN
      – PersonEntity:
          Name:
            NameFull: Rheingold SR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 05
              Text: 2026 May 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1